
A new European research initiative PRE-CISE has been launched with the aim of developing next-generation targeted alpha-therapies for cancer treatment. …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

